Welcome to LookChem.com Sign In|Join Free

CAS

  • or
4-(Trifluoromethoxy)phenyl isocyanate is an organic compound characterized by its clear colorless to slightly yellow liquid appearance. It is a chemical intermediate that plays a significant role in the synthesis of various pharmaceutical compounds.

35037-73-1 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 35037-73-1 Structure
  • Basic information

    1. Product Name: 4-(Trifluoromethoxy)phenyl isocyanate
    2. Synonyms: 4-(TRIFLUOROMETHOXY)PHENYL ISOCYANATE;1-ISOCYANATO-4-TRIFLUOROMETHOXY-BENZENE;p-(trifluoromethoxy)phenyl isocyanate;1-isocyanato-4-(trifluoromethoxy)-benzen;4-(TRIFLUOROMETHOXY)PHENYL ISOCYANATE, 9 8%;4-(trifluoromethoxy)phnyl isocyanate;4-(Trifluoromethoxy)phenyl isocyanate 98%;4-(Trifluoromethoxy)phenyl isocyanate 99%+
    3. CAS NO:35037-73-1
    4. Molecular Formula: C8H4F3NO2
    5. Molecular Weight: 203.12
    6. EINECS: 252-328-0
    7. Product Categories: Fluorobenzene;Boron, Nitrile, Thio,& TM-Cpds;Phenyl isocyanate&Phenyl isothiocyanate;Isocyanates;Nitrogen Compounds;Organic Building Blocks;Building Blocks;Chemical Synthesis;Nitrogen Compounds;Organic Building Blocks
    8. Mol File: 35037-73-1.mol
  • Chemical Properties

    1. Melting Point: -29°C
    2. Boiling Point: 78 °C (22 mmHg)
    3. Flash Point: 158 °F
    4. Appearance: clear colorless to slightly yellow liquid
    5. Density: 1.346 g/mL at 25 °C(lit.)
    6. Vapor Pressure: 1.42hPa at 25℃
    7. Refractive Index: n20/D 1.458(lit.)
    8. Storage Temp.: Refrigerator (+4°C)
    9. Solubility: N/A
    10. Water Solubility: Reacts with water.
    11. Sensitive: Moisture Sensitive
    12. BRN: 977669
    13. CAS DataBase Reference: 4-(Trifluoromethoxy)phenyl isocyanate(CAS DataBase Reference)
    14. NIST Chemistry Reference: 4-(Trifluoromethoxy)phenyl isocyanate(35037-73-1)
    15. EPA Substance Registry System: 4-(Trifluoromethoxy)phenyl isocyanate(35037-73-1)
  • Safety Data

    1. Hazard Codes: Xn,Xi
    2. Statements: 20/21/22-36/37/38-42
    3. Safety Statements: 26-36-36/37-22
    4. RIDADR: UN 2206 6.1/PG 3
    5. WGK Germany: 3
    6. RTECS:
    7. F: 21
    8. TSCA: Yes
    9. HazardClass: 6.1
    10. PackingGroup: III
    11. Hazardous Substances Data: 35037-73-1(Hazardous Substances Data)

35037-73-1 Usage

Uses

Used in Pharmaceutical Industry:
4-(Trifluoromethoxy)phenyl isocyanate is used as a reactant for the synthesis of 4-aryl-7-hydroxyindoline-based P2Y1 antagonists, which are novel antiplatelet agents. These antagonists have potential applications in the prevention and treatment of blood clot-related disorders, such as stroke, heart attack, and deep vein thrombosis, due to their ability to inhibit platelet aggregation.

Check Digit Verification of cas no

The CAS Registry Mumber 35037-73-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,5,0,3 and 7 respectively; the second part has 2 digits, 7 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 35037-73:
(7*3)+(6*5)+(5*0)+(4*3)+(3*7)+(2*7)+(1*3)=101
101 % 10 = 1
So 35037-73-1 is a valid CAS Registry Number.
InChI:InChI=1/C8H4F3NO2/c9-8(10,11)14-7-3-1-6(2-4-7)12-5-13/h1-4H

35037-73-1 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (T2487)  4-(Trifluoromethoxy)phenyl Isocyanate  >98.0%(GC)

  • 35037-73-1

  • 5g

  • 760.00CNY

  • Detail
  • TCI America

  • (T2487)  4-(Trifluoromethoxy)phenyl Isocyanate  >98.0%(GC)

  • 35037-73-1

  • 25g

  • 2,650.00CNY

  • Detail
  • Alfa Aesar

  • (B20033)  4-(Trifluoromethoxy)phenyl isocyanate, 97%   

  • 35037-73-1

  • 1g

  • 572.0CNY

  • Detail
  • Alfa Aesar

  • (B20033)  4-(Trifluoromethoxy)phenyl isocyanate, 97%   

  • 35037-73-1

  • 5g

  • 2300.0CNY

  • Detail
  • Alfa Aesar

  • (B20033)  4-(Trifluoromethoxy)phenyl isocyanate, 97%   

  • 35037-73-1

  • 25g

  • 8659.0CNY

  • Detail

35037-73-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-(Trifluoromethoxy)phenyl isocyanate

1.2 Other means of identification

Product number -
Other names p-(trifluoromethoxy)phenol

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only. Intermediates
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:35037-73-1 SDS

35037-73-1Relevant articles and documents

Design, synthesis and anticancer activity of a new series of n-aryl-n′-[4-(Pyridin-2-ylmethoxy)benzyl]urea derivatives

Hou, Shicheng,Liang, Shishao,Zhang, Chao,Han, Yingmei,Liang, Jianhui,Hu, Hongyu,Zhang, Xingeng,Hu, Chun,Liu, Xiaoping,Zhang, Hong

, (2021/06/25)

The development of cancer treatments requires continuous exploration and improvement, in which the discovery of new drugs for the treatment of cancer is still an important pathway. In this study, based on the molecular hybridization strategy, a new structural framework with an N-aryl-N’-arylmethylurea scaffold was designed, and 16 new target compounds were synthesized and evaluated for their antiproliferative activities against four different cancer cell lines A549, MCF7, HCT116, PC3, and human liver normal cell line HL7702. The results have shown seven compounds with 1-methylpiperidin-4-yl groups having excellent activities against all four cancer cell lines, and they exhibited scarcely any activities against HL7702. Among them, compound 9b and 9d showed greatly excellent activity against the four kinds of cells, and the IC50 for MCF7 and PC3 cell lines were even less than 3μM.

Electrochemically Enabled Intramolecular Aminooxygenation of Alkynes via Amidyl Radical Cyclization

Hou, Zhong-Wei,Xu, Hai-Chao

supporting information, p. 394 - 398 (2020/03/04)

An electrochemical synthesis of oxazol-2-ones and imidazol-2-ones has been developed via 5-exo-dig cyclization of propargylic carbamates- and ureas-derived amidyl radicals. The electrosynthesis relies on the dual function of 2,2,6,6-tetramethylpiperidin- 1-yl)oxyl (TEMPO) as a redox mediator for amidyl radical formation and an oxygen atom donor. The reactions are conducted under mild conditions using a simple setup and provide convenient access to functionalized oxazol-2-ones and imidazol-2-ones from readily available materials.

Synthesis and structure-activity relationship study of pyrrolidine-oxadiazoles as anthelmintics against Haemonchus contortus

Ruan, Banfeng,Zhang, Yuezhou,Tadesse, Solomon,Preston, Sarah,Taki, Aya C.,Jabbar, Abdul,Hofmann, Andreas,Jiao, Yaqing,Garcia-Bustos, Jose,Harjani, Jitendra,Le, Thuy Giang,Varghese, Swapna,Teguh, Silvia,Xie, Yiyue,Odiba, Jephthah,Hu, Min,Gasser, Robin B.,Baell, Jonathan

supporting information, (2020/02/04)

Parasitic roundworms (nematodes) are significant pathogens of humans and animals and cause substantive socioeconomic losses due to the diseases that they cause. The control of nematodes in livestock animals relies heavily on the use of anthelmintic drugs. However, their extensive use has led to a widespread problem of drug resistance in these worms. Thus, the discovery and development of novel chemical entities for the treatment of parasitic worms of humans and animals is needed. Herein, we describe our medicinal chemistry optimization efforts of a phenotypic hit against Haemonchus contortus based on a pyrrolidine-oxadiazole scaffold. This led to the identification of compounds with potent inhibitory activities (IC50 = 0.78–22.4 μM) on the motility and development of parasitic stages of H. contortus, and which were found to be highly selective in a mammalian cell counter-screen. These compounds could be used as suitable chemical tools for drug target identification or as lead compounds for further optimization.

The cubane paradigm in bioactive molecule discovery: Further scope, limitations and the cyclooctatetraene complement

Houston, Sevan D.,Fahrenhorst-Jones, Tyler,Xing, Hui,Chalmers, Benjamin A.,Sykes, Melissa L.,Stok, Jeanette E.,Farfan Soto, Clementina,Burns, Jed M.,Bernhardt, Paul V.,De Voss, James J.,Boyle, Glen M.,Smith, Maree T.,Tsanaktsidis, John,Savage, G. Paul,Avery, Vicky M.,Williams, Craig M.

supporting information, p. 6790 - 6798 (2019/07/22)

The cubane phenyl ring bioisostere paradigm was further explored in an extensive study covering a wide range of pharmaceutical and agrochemical templates, which included antibiotics (cefaclor, penicillin G) and antihistamine (diphenhydramine), a smooth muscle relaxant (alverine), an anaesthetic (ketamine), an agrochemical instecticide (triflumuron), an antiparasitic (benznidazole) and an anticancer agent (tamibarotene). This investigation highlights the scope and limitations of incorporating cubane into bioactive molecule discovery, both in terms of synthetic compatibility and physical property matching. Cubane maintained bioisosterism in the case of the Chagas disease antiparasitic benznidazole, although it was less active in the case of the anticancer agent (tamibarotenne). Application of the cyclooctatetraene (COT) (bio)motif complement was found to optimize benznidazole relative to the benzene parent, and augmented anticancer activity relative to the cubane analogue in the case of tamibarotene. Like all bioisosteres, scaffolds and biomotifs, however, there are limitations (e.g. synthetic implementation), and these have been specifically highlighted herein using failed examples. A summary of all templates prepared to date by our group that were biologically evaluated strongly supports the concept that cubane is a valuable tool in bioactive molecule discovery and COT is a viable complement.

Phenylquinoline transient receptor potential vanilloid 1 antagonists for the treatment of pain: Discovery of 1-(2-phenylquinoline-4-carbonyl)-N-(4-(trifluoromethyl)phenyl)pyrrolidine-3-carboxamide

Liao, Chen,Liu, Yan,Liu, Chunxia,Zhou, Jiaqi,Li, Huilan,Wang, Nasi,Li, Jieming,Liu, Taiyu,Ghaleb, Hesham,Huang, Wenlong,Qian, Hai

, p. 845 - 854 (2018/01/10)

Reported herein is the design, synthesis, and pharmacologic characterization of a class of TRPV1 antagonists constructed on a phenylquinoline platform that evolved from Cinchophen lead. This design composes three sections: a phenylquinoline headgroup attached to an aliphatic carboxamides, which is tethered at a phenyl tail group. Optimization of this design led to the identification of 37, comprising a pyrrolidine linker and a trifluoromethyl–phenyl tail. In the TRPV1 functional assay, using cells expressed hTRPV1, 37 antagonized capsaicin-induced Ca2+ influx, with an IC50 value of 10.2 nM. In the complete mice analgesic model, 37 exhibited better antinociceptive activity than the positive control BCTC in diverse pain models. All of these results suggested that 37 could be considered as a lead candidate for the further development of antinociceptive drugs.

Design, synthesis and biological evaluation of artemisinin derivatives containing fluorine atoms as anticancer agents

Li, Shu,Li, Gongming,Yang, Xiaohong,Meng, Qian,Yuan, Shuo,He, Yun,Sun, Dequn

supporting information, p. 2275 - 2278 (2018/05/24)

Ten novel artemisinin derivatives containing fluorine atoms were synthesized and their structures were confirmed by 1H NMR, 13C NMR and HRMS technologies in this study. The in vitro cytotoxicity against U87MG, SH-SY5Y, MCF-7, MDA-MB-231, A549 and A375 cancer cell lines was evaluated by MTT assay. Compound 9j was the most potent anti-proliferative agent against the human breast cancer MCF-7 cells (IC50 = 2.1 μM). The mechanism of action of compound 9j was further investigated by analysis of cell apoptosis and cell cycle. Compound 9j induced cell apoptosis and arrested cell cycle at G1 phase in MCF-7 cells. Our promising findings indicated that the compound 9j could stand as potential lead compound for further investigation.

Synthesis method of indoxacarb intermediate semicarbazone

-

Paragraph 0044; 0045, (2017/08/30)

The invention discloses a synthesis method of an indoxacarb intermediate semicarbazone. The synthesis method includes the steps of producing 4-trifluoromethoxy phenylurea from 4-trifluoromethoxyaniline and isocyanate under the action of acetic acid; enabling the 4-trifluoromethoxy phenylurea and hydrazine hydrate to undergo hydrazinolysis in an organic solvent so as to obtain 4-trifluoromethoxy phenylamino hydrazide; enabling the 4-trifluoromethoxy phenylamino hydrazide and 5-chloro-1,3-dihydro-2-hydroxy-1-oxo-2H-indene-2-carboxylic acid methyl ester in an organic solvent under the action of a catalyst. The synthesis method has the advantages that the intermediate semicarbazone is synthesized from industrially available isocyanate through a series of conversion, and accordingly the synthesis method is free of toxic substances and phosgene products and capable of avoiding the shortcomings of high cost and low yield when precious metals serve as catalysts as well as overcoming the technical defect of low ring-closure reaction yield; the synthesis method is high in safety and is economical and high in yield when used for synthesizing indoxacarb atoms.

Discovery of novel anti-angiogenesis agents. Part 8: Diaryl thiourea bearing 1H-indazole-3-amine as multi-target RTKs inhibitors

Sun, Ying,Shan, Yuanyuan,Li, Chuansheng,Si, Ru,Pan, Xiaoyan,Wang, Binghe,Zhang, Jie

, p. 373 - 385 (2017/10/16)

VEGFR-2, TIE-2, and EphB4 are essential for both angiogenesis and tumorigenesis. Herein, we designed and prepared three classes of multi-target inhibitors based on the extensive sequence homology along the kinase domain of angiogenic RTKs. Biological evaluation indicated that these multi-target inhibitors exhibited considerable potential as novel anti-angiogeneic and anticancer agents. Among them, a diaryl thiourea bearing 1H-indazole-3-amine (16a) displayed the most potent RTK inhibition and excellent selectivity. It also showed inhibition on viability of human umbilical vein endothelial cells and anti-proliferation against a broad spectrum of cancer cells. Therefore, 1H-indazole-3-amine could serve as a promising hinge binding group for multi-target inhibitors of VEGFR-2, Tie-2, and EphB4.

Discovery of novel anti-angiogenesis agents. Part 7: Multitarget inhibitors of VEGFR-2, TIE-2 and EphB4

Li, Chuansheng,Shan, Yuanyuan,Sun, Ying,Si, Ru,Liang, Liyuan,Pan, Xiaoyan,Wang, Binghe,Zhang, Jie

, p. 506 - 518 (2017/11/14)

Herein, we embarked on a structural optimization campaign aiming at the discovery of second generation anti-angiogenesis agents with our previously reported BPS-7 as lead compound. A library of 27 compounds has been afforded based on the highly conserved ATP-binding pocket of VEGFR-2, Tie-2, and EphB4. Several title compounds exhibited simultaneous inhibitory effects against three angiogenic RTKs. These compounds with a ‘triplet’ inhibition profile have been identified as novel anti-angiogenic and anticancer agents. The representative VDAU11 displayed prominent anti-angiogenic and anticancer potency and could be considered as a candidate for further optimization. These results indicate that N-(pyridin-2-yl)acrylamide could serve as a novel hinge-binding group of triple inhibitors.

Design, synthesis and structure-activity relationships of novel diaryl urea derivatives as potential EGFR inhibitors

Jiang, Nan,Bu, Yanxin,Wang, Yu,Nie, Minhua,Zhang, Dajun,Zhai, Xin

, (2016/12/03)

Two novel series of diaryl urea derivatives 5a-i and 13a-l were synthesized and evaluated for their cytotoxicity against H-460, HT-29, A549, and MDA-MB-231 cancer cell lines in vitro. Therein, 4-aminoquinazolinyl-diaryl urea derivatives 5a-i demonstrated significant activity, and seven of them are more active than sorafenib, with IC50 values ranging from 0.089 to 5.46 μM. Especially, compound 5a exhibited the most active potency both in cellular (IC50 = 0.15, 0.089, 0.36, and 0.75 μM, respectively) and enzymatic assay (IC50 = 56 nM against EGFR), representing a promising lead for further optimization.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 35037-73-1